Prescriptions

Ozempic Alternatives for Weightlosss - Berberine, Metformin, Trulicity

Khang T. Vuong, MHA
Khang T. Vuong, MHA28 Jun 2023

There are 5 categories of semaglutide alternatives for blood sugar control: (1) GLP-1 drugs such as exenatide, liraglutide, and dulaglutide; (2) DPP-4 inhibitors (e.g., sitagliptin, linagliptin),(3) SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin), (4) metformin, and (5) natural supplements such as cinnamon, berberine, and bitter melon. These alternatives work through different mechanisms and have varying clinical evidence and side effects. GLP-1 drugs are the most effective alternatives to semaglutide, while the efficacy of natural supplements is less established and requires further research. Consult with healthcare professionals before making changes to diabetes management plans.

Drug Name

Evidence of Efficacy in Aiding Weight Loss

Exenatide (Byetta, Bydureon)Studies have shown that exenatide can lead to weight loss, possibly due to its effects on slowing gastric emptying and increasing feelings of fullness.
Liraglutide (Victoza, Saxenda)A higher dose of Liraglutide (3.0 mg) is approved for weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related condition, or in adults with a BMI of 30 kg/m² or greater.
Dulaglutide (Trulicity)Dulaglutide has been associated with weight loss in clinical trials. The precise mechanism of weight loss with dulaglutide is not known.
Sitagliptin (Januvia), Linagliptin (Tradjenta)These DPP-4 inhibitors are weight-neutral, meaning they do not typically cause weight gain or loss.
Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance)SGLT2 inhibitors have been associated with modest weight loss in clinical trials, possibly due to the increased glucose excretion in the urine.
MetforminMetformin is typically weight neutral, but some people may experience slight weight loss, possibly due to improved insulin sensitivity and decreased appetite. (source)
Cinnamon, Berberine, Bitter MelonWhile these natural supplements may have potential blood sugar-lowering effects, the evidence for their efficacy in aiding weight loss is limited and inconsistent. More research is needed.

1. Other GLP-1 receptor agonists

Semaglutide (Ozempic, Wegovy) belongs to a class of medications called GLP-1 receptor agonists. Several other drugs in this class offer alternative options for managing blood sugar levels in people with type 2 diabetes.

1. Exenatide (Byetta, Bydureon)

Exenatide is a GLP-1 receptor agonist that mimics the action of GLP-1, a hormone that increases insulin secretion and suppresses glucagon release. Like Ozempic and Wegovy, exenatide helps improve blood sugar control in people with type 2 diabetes.

Clinical evidence: A 5-year study published in the journal "Diabetes, Obesity and Metabolism" showed significant improvements in glycemic control among participants treated with exenatide (source: "Effects of Exenatide on Systemic and WAT Inflammation" - PubMed).

Side effects: Common side effects of exenatide include nausea, vomiting, diarrhea, and headache. These side effects are similar to those experienced by some people using semaglutide (source: Byetta prescribing information - FDA).

2. Liraglutide (Victoza, Saxenda)

Liraglutide is another GLP-1 receptor agonist that activates the GLP-1 receptor, stimulating insulin secretion and inhibiting glucagon release. It aids in blood sugar control in patients with type 2 diabetes, much like Ozempic. 

Clinical evidence: The LEADER trial, published in the New England Journal of Medicine, demonstrated that liraglutide reduced the risk of major cardiovascular events in people with type 2 diabetes with a high risk of cardiovascular disease when compared to placebo (source: "Liraglutide and cardiovascular outcomes in type 2 diabetes" - NEJM).

Side effects: Common side effects of liraglutide include nausea, vomiting, diarrhea, and decreased appetite. These side effects are comparable to those experienced by some people using semaglutide (source: Victoza prescribing information - FDA).

3. Dulaglutide (Trulicity)

Dulaglutide is a GLP-1 receptor agonist that increases insulin secretion and decreases glucagon release, helping improve blood sugar control in people with type 2 diabetes.

Clinical evidence: A study published in the journal "Diabetes Care" showed that dulaglutide demonstrated improvements in glycemic control without increasing the risk of adverse events when compared to sitagliptin, a DPP-4 inhibitor (source: "Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial" - PubMed Central).

Side effects: Some common side effects of dulaglutide include nausea, vomiting, diarrhea, and abdominal pain, which are similar to the side effects of semaglutide (source: Trulicity prescribing information - FDA).

Health Image

Get Mira - Health Benefits You Can Afford.

Get doctor visits, lab tests, prescription, and more. Affordable copays. Available in 45+ states. Only $45/month on average.

2. DPP-4 inhibitors (gliptins)

DPP-4 inhibitors, also known as gliptins, are another class of medications that can be used to manage blood sugar levels in people with type 2 diabetes. Examples of DPP-4 inhibitors include sitagliptin (Januvia), linagliptin (Tradjenta), saxagliptin (Onglyza), and alogliptin (Nesina).

How they work: DPP-4 inhibitors work by inhibiting the action of the DPP-4 enzyme, which prolongs the action of incretin hormones. This, in turn, enhances glucose-stimulated insulin secretion and suppresses glucagon release, resulting in improved blood sugar control.

Clinical evidence: According to UpToDate, DPP-4 inhibitors can reduce A1C levels by around 0.5-0.8%. This is lower than the 1-1.9% reduction achieved with semaglutide but still offers a noticeable improvement in glycemic control for people with type 2 diabetes.

Side effects: Side effects of DPP-4 inhibitors are generally mild and may include headaches, sore throat, and upper respiratory tract infections.

3. SGLT2 inhibitors (gliflozins)

SGLT2 inhibitors, another class of diabetes medications, offer further alternative options for managing blood sugar levels in people with type 2 diabetes if Ozempic and Wegovy are inaccessible. Examples of SGLT2 inhibitors include canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance).

How they work: SGLT2 inhibitors block the SGLT2 protein in the kidneys, which inhibits glucose reabsorption and promotes glucosuria (the excretion of glucose in the urine). This ultimately results in lower blood sugar levels.

Clinical evidence: A systematic review published in the journal "Cardiovascular Diabetology" reported that SGLT2 inhibitors demonstrated A1C reductions of greater than 1% in clinical trials. This is similar to the reductions achieved with semaglutide, making SGLT2 inhibitors a promising alternative for improving glycemic control (source: "SGLT2 Inhibitors: A Systematic Review" - PubMed Central).

Side effects: Common side effects of SGLT2 inhibitors include urinary tract infections, hypotension, and increased thirst.

4. Metformin

Metformin is a widely used first-line medication for treating type 2 diabetes and can also be considered a lower-cost alternative to semaglutide (Ozempic).

How it works: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in muscle cells, which helps lower blood sugar levels.

Clinical evidence: According to UpToDate, metformin typically reduces A1C levels by 1-2%, which is comparable to the reductions achieved with semaglutide. However, metformin has a lower risk of hypoglycemia compared to semaglutide and other GLP-1 receptor agonists.

Side effects: Common side effects of metformin include gastrointestinal symptoms such as diarrhea, nausea, and abdominal pain. Rarely, metformin can cause lactic acidosis, a potentially serious condition.

5. Natural supplements

While not as effective as prescription medications, some natural supplements have purported blood sugar-lowering effects and may offer benefits to people with type 2 diabetes. They tend to be much cheaper and with less known side effects, though not as clinically effective. 

Health Image

Virtual care for only $25 per visit

Virtual primary care, urgent care, and behavioral health visits are only $25 with a Mira membership.

Cinnamon

Clinical evidence: Some studies have shown that cinnamon can help lower blood sugar levels. However, more research is needed to establish its effectiveness as a diabetes treatment. A review published in the journal "Diabetes Care" reported that cinnamon intake reduced fasting blood glucose levels (source: "Cinnamon intake lowers fasting blood glucose" - PubMed Central).

Berberine

Clinical evidence: Berberine, an herbal compound found in plants like goldenseal and barberry, has demonstrated blood sugar-lowering effects in some studies. In a study published in the journal "Metabolism," berberine was found to be as effective as metformin in reducing blood glucose levels in people with type 2 diabetes (source: "Efficacy of Berberine in Patients with Type 2 Diabetes" - PubMed Central).

Bitter melon

Clinical evidence: Bitter melon (Momordica charantia) is a vegetable that has been used in traditional medicine for its potential anti-diabetic properties. Limited evidence suggests that bitter melon can help lower blood glucose levels, but more research is needed to confirm its effectiveness. A review published in the journal "Frontiers in Pharmacology" reported improved blood sugar control in animal studies with bitter melon, but the results in human studies are inconsistent (source: "Bitter Melon (Momordica charantia) as a potential anti-diabetic agent" - PubMed Central).

How much do semaglutide alternatives cost?

The cost of weight loss medications is not cheap, especially when you are most likely to have to depend on these medications long-term for blood sugar control and appetite suppression. The best method of weight loss is lifestyle change, while it is free, it is extremely difficult to achieve. But it doesn’t have to be either or, you could adopt a hybrid strategy where medications function as a booster along with lifestyle modifications. 

DrugAverage CostPrescription Needed
Semaglutide (Ozempic, Rybelsus)$1,300-$1,500 per monthYes
Exenatide (Byetta, Bydureon)$700-$900 per monthYes
Liraglutide (Victoza, Saxenda)$600-$800 per monthYes
Dulaglutide (Trulicity)$500-$700 per monthYes
Sitagliptin (Januvia)$300-$400 per monthYes
Linagliptin (Tradjenta)$200-$300 per monthYes
Saxagliptin (Onglyza)$100-$200 per monthYes
Alogliptin (Nesina)$50-$100 per monthYes
Canagliflozin (Invokana)$500-$700 per monthYes
Dapagliflozin (Farxiga)$400-$600 per monthYes
Empagliflozin (Jardiance)$300-$500 per monthYes
Metformin$10-$20 per monthYes
Cinnamon$10-$20 per monthNo
Berberine$20-$30 per monthNo
Bitter melon$10-$20 per monthNo

Takeaways:

In summary, there are several alternatives to semaglutide, including other GLP-1 receptor agonists like exenatide, liraglutide, and dulaglutide, as well as medications from different classes such as DPP-4 inhibitors, SGLT2 inhibitors, and metformin. Natural supplements like cinnamon, berberine, and bitter melon may also offer some blood sugar-lowering benefits.

Overall, GLP-1 receptor agonists are the most effective alternatives to semaglutide and offer similar mechanisms of action. However, it is important to note that the effectiveness of each medication or supplement may vary depending on the individual, and side effect profiles differ between these alternatives. It is essential to consult with a healthcare professional before making any changes to your diabetes management plan.

Khang T. Vuong, MHA

Khang T. Vuong received his Master of Healthcare Administration from the Milken Institute School of Public Health at the George Washington University. He was named Forbes Healthcare 2021 30 under 30. Vuong spoke at Stanford Medicine X, HIMSS conference, and served as a Fellow at the Bon Secours Health System.